Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 06:24:01 UTC |
---|
Update Date | 2021-09-26 23:00:42 UTC |
---|
HMDB ID | HMDB0249674 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Carfilzomib |
---|
Description | Carfilzomib belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Based on a literature review very few articles have been published on Carfilzomib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Carfilzomib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Carfilzomib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1 InChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49) |
---|
Synonyms | Value | Source |
---|
2-[(1-Hydroxy-2-{[1-hydroxy-2-(morpholin-4-yl)ethylidene]amino}-4-phenylbutylidene)amino]-4-methyl-N-(1-{[4-methyl-1-(2-methyloxiran-2-yl)-1-oxopentan-2-yl]-C-hydroxycarbonimidoyl}-2-phenylethyl)pentanimidate | HMDB |
|
---|
Chemical Formula | C40H57N5O7 |
---|
Average Molecular Weight | 719.924 |
---|
Monoisotopic Molecular Weight | 719.425799195 |
---|
IUPAC Name | 4-methyl-N-(1-{[4-methyl-1-(2-methyloxiran-2-yl)-1-oxopentan-2-yl]carbamoyl}-2-phenylethyl)-2-{2-[2-(morpholin-4-yl)acetamido]-4-phenylbutanamido}pentanamide |
---|
Traditional Name | carfilzomib |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1 |
---|
InChI Identifier | InChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49) |
---|
InChI Key | BLMPQMFVWMYDKT-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Oligopeptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-oligopeptide
- Phenylalanine or derivatives
- Leucine or derivatives
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- N-substituted-alpha-amino acid
- Alpha-amino acid or derivatives
- Amphetamine or derivatives
- Morpholine
- N-acyl-amine
- Fatty amide
- Oxazinane
- Benzenoid
- Fatty acyl
- Monocyclic benzene moiety
- Tertiary amine
- Tertiary aliphatic amine
- Amino acid or derivatives
- Carboxamide group
- Ketone
- Secondary carboxylic acid amide
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Dialkyl ether
- Oxirane
- Ether
- Carbonyl group
- Organic oxygen compound
- Organic oxide
- Amine
- Hydrocarbon derivative
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Carfilzomib,1TMS,isomer #1 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)=C(O[Si](C)(C)C)C1(C)CO1 | 5113.8 | Semi standard non polar | 33892256 | Carfilzomib,1TMS,isomer #1 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)=C(O[Si](C)(C)C)C1(C)CO1 | 4455.0 | Standard non polar | 33892256 | Carfilzomib,1TMS,isomer #1 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)=C(O[Si](C)(C)C)C1(C)CO1 | 7017.7 | Standard polar | 33892256 | Carfilzomib,1TMS,isomer #2 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)C1(C)CO1 | 4938.5 | Semi standard non polar | 33892256 | Carfilzomib,1TMS,isomer #2 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)C1(C)CO1 | 4529.5 | Standard non polar | 33892256 | Carfilzomib,1TMS,isomer #2 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)C1(C)CO1 | 6919.4 | Standard polar | 33892256 | Carfilzomib,1TMS,isomer #3 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1 | 4938.4 | Semi standard non polar | 33892256 | Carfilzomib,1TMS,isomer #3 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1 | 4549.7 | Standard non polar | 33892256 | Carfilzomib,1TMS,isomer #3 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1 | 6921.0 | Standard polar | 33892256 | Carfilzomib,1TMS,isomer #4 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N(C(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 4984.5 | Semi standard non polar | 33892256 | Carfilzomib,1TMS,isomer #4 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N(C(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 4540.6 | Standard non polar | 33892256 | Carfilzomib,1TMS,isomer #4 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N(C(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 6916.4 | Standard polar | 33892256 | Carfilzomib,1TMS,isomer #5 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 5014.8 | Semi standard non polar | 33892256 | Carfilzomib,1TMS,isomer #5 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 4504.1 | Standard non polar | 33892256 | Carfilzomib,1TMS,isomer #5 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 6915.9 | Standard polar | 33892256 | Carfilzomib,2TMS,isomer #1 | CC(C)CC(=C(O[Si](C)(C)C)C1(C)CO1)N(C(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C | 4920.6 | Semi standard non polar | 33892256 | Carfilzomib,2TMS,isomer #1 | CC(C)CC(=C(O[Si](C)(C)C)C1(C)CO1)N(C(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C | 4207.2 | Standard non polar | 33892256 | Carfilzomib,2TMS,isomer #1 | CC(C)CC(=C(O[Si](C)(C)C)C1(C)CO1)N(C(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C | 6599.9 | Standard polar | 33892256 | Carfilzomib,2TMS,isomer #10 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N(C(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C)[Si](C)(C)C | 4842.4 | Semi standard non polar | 33892256 | Carfilzomib,2TMS,isomer #10 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N(C(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C)[Si](C)(C)C | 4557.3 | Standard non polar | 33892256 | Carfilzomib,2TMS,isomer #10 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N(C(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C)[Si](C)(C)C | 6532.9 | Standard polar | 33892256 | Carfilzomib,2TMS,isomer #2 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)N(C(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)=C(O[Si](C)(C)C)C1(C)CO1 | 4980.8 | Semi standard non polar | 33892256 | Carfilzomib,2TMS,isomer #2 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)N(C(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)=C(O[Si](C)(C)C)C1(C)CO1 | 4438.9 | Standard non polar | 33892256 | Carfilzomib,2TMS,isomer #2 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)N(C(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)=C(O[Si](C)(C)C)C1(C)CO1 | 6656.0 | Standard polar | 33892256 | Carfilzomib,2TMS,isomer #3 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)=C(O[Si](C)(C)C)C1(C)CO1 | 4923.6 | Semi standard non polar | 33892256 | Carfilzomib,2TMS,isomer #3 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)=C(O[Si](C)(C)C)C1(C)CO1 | 4435.7 | Standard non polar | 33892256 | Carfilzomib,2TMS,isomer #3 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)=C(O[Si](C)(C)C)C1(C)CO1 | 6657.7 | Standard polar | 33892256 | Carfilzomib,2TMS,isomer #4 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)=C(O[Si](C)(C)C)C1(C)CO1 | 4936.9 | Semi standard non polar | 33892256 | Carfilzomib,2TMS,isomer #4 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)=C(O[Si](C)(C)C)C1(C)CO1 | 4437.7 | Standard non polar | 33892256 | Carfilzomib,2TMS,isomer #4 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)=C(O[Si](C)(C)C)C1(C)CO1 | 6658.8 | Standard polar | 33892256 | Carfilzomib,2TMS,isomer #5 | CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C | 4799.0 | Semi standard non polar | 33892256 | Carfilzomib,2TMS,isomer #5 | CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C | 4568.6 | Standard non polar | 33892256 | Carfilzomib,2TMS,isomer #5 | CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C | 6525.4 | Standard polar | 33892256 | Carfilzomib,2TMS,isomer #6 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)N(C(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)[Si](C)(C)C)C(=O)C1(C)CO1 | 4801.9 | Semi standard non polar | 33892256 | Carfilzomib,2TMS,isomer #6 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)N(C(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)[Si](C)(C)C)C(=O)C1(C)CO1 | 4584.8 | Standard non polar | 33892256 | Carfilzomib,2TMS,isomer #6 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)N(C(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C)[Si](C)(C)C)C(=O)C1(C)CO1 | 6535.8 | Standard polar | 33892256 | Carfilzomib,2TMS,isomer #7 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)[Si](C)(C)C)C(=O)C1(C)CO1 | 4783.7 | Semi standard non polar | 33892256 | Carfilzomib,2TMS,isomer #7 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)[Si](C)(C)C)C(=O)C1(C)CO1 | 4577.3 | Standard non polar | 33892256 | Carfilzomib,2TMS,isomer #7 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)[Si](C)(C)C)C(=O)C1(C)CO1 | 6540.1 | Standard polar | 33892256 | Carfilzomib,2TMS,isomer #8 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)N(C(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 4806.3 | Semi standard non polar | 33892256 | Carfilzomib,2TMS,isomer #8 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)N(C(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 4595.1 | Standard non polar | 33892256 | Carfilzomib,2TMS,isomer #8 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)N(C(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 6530.6 | Standard polar | 33892256 | Carfilzomib,2TMS,isomer #9 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 4818.5 | Semi standard non polar | 33892256 | Carfilzomib,2TMS,isomer #9 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 4565.6 | Standard non polar | 33892256 | Carfilzomib,2TMS,isomer #9 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C | 6528.2 | Standard polar | 33892256 | Carfilzomib,1TBDMS,isomer #1 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)=C(O[Si](C)(C)C(C)(C)C)C1(C)CO1 | 5317.6 | Semi standard non polar | 33892256 | Carfilzomib,1TBDMS,isomer #1 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)=C(O[Si](C)(C)C(C)(C)C)C1(C)CO1 | 4607.3 | Standard non polar | 33892256 | Carfilzomib,1TBDMS,isomer #1 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)=C(O[Si](C)(C)C(C)(C)C)C1(C)CO1 | 6989.0 | Standard polar | 33892256 | Carfilzomib,1TBDMS,isomer #2 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C(C)(C)C)C(=O)C1(C)CO1 | 5159.3 | Semi standard non polar | 33892256 | Carfilzomib,1TBDMS,isomer #2 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C(C)(C)C)C(=O)C1(C)CO1 | 4670.3 | Standard non polar | 33892256 | Carfilzomib,1TBDMS,isomer #2 | CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)N(C(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)[Si](C)(C)C(C)(C)C)C(=O)C1(C)CO1 | 6845.3 | Standard polar | 33892256 | Carfilzomib,1TBDMS,isomer #3 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C(C)(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1 | 5158.9 | Semi standard non polar | 33892256 | Carfilzomib,1TBDMS,isomer #3 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C(C)(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1 | 4682.7 | Standard non polar | 33892256 | Carfilzomib,1TBDMS,isomer #3 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)N(C(=O)CN1CCOCC1)[Si](C)(C)C(C)(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1 | 6843.5 | Standard polar | 33892256 | Carfilzomib,1TBDMS,isomer #4 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N(C(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C(C)(C)C | 5208.8 | Semi standard non polar | 33892256 | Carfilzomib,1TBDMS,isomer #4 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N(C(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C(C)(C)C | 4676.7 | Standard non polar | 33892256 | Carfilzomib,1TBDMS,isomer #4 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N(C(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C(C)(C)C | 6842.7 | Standard polar | 33892256 | Carfilzomib,1TBDMS,isomer #5 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C(C)(C)C | 5225.1 | Semi standard non polar | 33892256 | Carfilzomib,1TBDMS,isomer #5 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C(C)(C)C | 4649.2 | Standard non polar | 33892256 | Carfilzomib,1TBDMS,isomer #5 | CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)NC(CC1=CC=CC=C1)C(=O)N(C(CC(C)C)C(=O)C1(C)CO1)[Si](C)(C)C(C)(C)C | 6848.8 | Standard polar | 33892256 |
| Show more...
---|